Valuation: Danaher Corporation

Market Cap 17TCr 15TCr 14TCr 12TCr 23TCr 15,50500Cr 24TCr 1,62500Cr 65TCr 8,30100Cr 62TCr 61TCr 26,14400Cr P/E 2026 *
37.4x
P/E 2027 * 31.3x
Enterprise Value 19TCr 17TCr 15TCr 14TCr 26TCr 17,43400Cr 27TCr 1,82700Cr 73TCr 9,33300Cr 70TCr 68TCr 29,39600Cr EV / Sales 2026 *
7.08x
EV / Sales 2027 * 6.42x
Free-Float
70.57%
Yield 2026 *
0.62%
Yield 2027 * 0.67%
1 day+2.12%
1 week+3.14%
Current month+1.24%
1 month+6.97%
3 months+14.83%
6 months+37.37%
Current year+2.71%
1 week 222.96
Extreme 222.96
238.45
1 month 217.55
Extreme 217.55
238.46
Current year 160.93
Extreme 160.93
242.8
1 year 160.93
Extreme 160.93
242.8
3 years 160.93
Extreme 160.93
281.7
5 years 160.93
Extreme 160.93
331.68
10 years 76.27
Extreme 76.27
333.96
Manager TitleAgeSince
Chief Executive Officer - 01/10/2026
Director of Finance/CFO - 28/02/2026
Chief Tech/Sci/R&D Officer - 25/08/2025
Director TitleAgeSince
Director/Board Member 74 01/07/1999
Chairman 74 01/01/1984
Director/Board Member 69 01/01/1984
Date Insider Type Main position Quantity % Market Cap. Importance
30/10/26 Free

Director

13 0.0000%
30/10/26 Free

Director

193 0.0000%
30/10/26 Free

Director

144 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+2.12%+3.14%+11.99%+20.25% 16TCr
+3.87%+5.71%+26.07%+62.43% 26TCr
+1.71%+5.42%-17.76%+69.07% 16TCr
+2.97%-0.68%-55.99%-14.41% 6.2TCr
+2.52%+12.28%+25.57%+61.96% 5.87TCr
-3.36%-0.55%-0.30%-10.70% 5.54TCr
+3.10%+4.76%+22.78%+67.23% 4.93TCr
+0.88%-0.20%+3.91%+83.91% 4.92TCr
+4.17%+6.04%+28.25%+88.36% 4.5TCr
+2.00%+5.63%+15.03%+23.01% 3.72TCr
Average +2.00%+4.03%+5.96%+45.11% 9TCr
Weighted average by Cap. +2.37%+4.40%+7.53%+47.81%

Financials

2026 *2027 *
Net sales 2.63TCr 2.34TCr 2.16TCr 1.96TCr 3.71TCr 2,46200Cr 3.8TCr 26TCr 10TCr 1,31800Cr 9.86TCr 9.65TCr 4,15100Cr 2.83TCr 2.52TCr 2.32TCr 2.11TCr 4TCr 2,65100Cr 4.09TCr 28TCr 11TCr 1,41900Cr 11TCr 10TCr 4,47000Cr
Net income 439.63Cr 392.42Cr 361.09Cr 327.72Cr 621.08Cr 41TCr 636.5Cr 4.32TCr 1.72TCr 22TCr 1.65TCr 1.61TCr 69TCr 521.52Cr 465.51Cr 428.35Cr 388.77Cr 736.77Cr 49TCr 755.06Cr 5.12TCr 2.04TCr 26TCr 1.96TCr 1.92TCr 82TCr
Net Debt 2.06TCr 1.84TCr 1.69TCr 1.53TCr 2.91TCr 1,92900Cr 2.98TCr 20TCr 8.06TCr 1,03300Cr 7.72TCr 7.56TCr 3,25200Cr 1.61TCr 1.44TCr 1.32TCr 1.2TCr 2.27TCr 1,50800Cr 2.33TCr 16TCr 6.3TCr 81TCr 6.04TCr 5.91TCr 2,54200Cr
Projected Income Statement - Annual - Danaher Corporation
Logo Danaher Corporation
Danaher Corporation is an industrial and technologic group organized around three families of products: - diagnostic equipment (40.5% of net sales); - life sciences equipment (29.8%); - biotechnology equipment (29.7%): ranging from basic biological research to the development and manufacturing of vaccines, biological drugs, cell and gene therapies, and new technologies such as mRNA. Net sales are distributed geographically as follows: the United States (40.6%), China (10.7%) and other (48.7%).
Employees
59,000
Date Price Change Volume
09/26/09 $235.12 +2.12% 36,30,558
06/26/06 $230.25 +1.73% 40,61,071
05/26/05 $226.34 -3.66% 51,38,041
04/26/04 $234.93 +2.09% 30,55,473
03/26/03 $230.11 +0.94% 26,88,094
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Danaher Corporation
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
235.12USD
Average target price
259.90USD
Spread / Average Target
+10.54%